Click Therapeutics Stock

Digital Therapeutics Applications

Sign up today and learn more about Click Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Flatiron Investors


New York NY, US

Total Funding


About Click Therapeutics Stock

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.


Flatiron Investors

Credijusto, Click Therapeutics

Hikma Ventures

Click Therapeutics

K2 HealthVentures

Inari, Click Therapeutics

Magellan Health Services

Click Therapeutics, NeuroFlow

Funding History

June 2018$33.1M
October 2021$57.8M


Chief Executive Officer

David Benshoof Klein

Chief Technology Officer

Christopher Jordan


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: